INTERIM HOME CARE UTAH

    Dementia Treatment: What Every Family Should Know

    Family discussing dementia treatment options with a physician.

    We're a non-medical home care agency — we don't prescribe or manage medical treatment. What we can offer is an honest, plain-English overview of what treatment options exist today, so you're prepared for the conversation with your loved one's doctor, not blindsided by it.

    There Is No Cure — Treatments Manage, Not Reverse

    This is worth saying plainly upfront: no current dementia treatment cures the disease or reverses existing damage. Available treatments either manage symptoms or, for a narrow group of early-stage patients, modestly slow progression. Understanding this distinction helps set realistic expectations before any treatment conversation starts.

    Symptomatic Medications: The Established Options

    Cholinesterase inhibitors (donepezil, rivastigmine, galantamine, and newer options) are the most commonly prescribed dementia medications. They don't stop the underlying disease, but they can help manage memory and thinking symptoms for a period of time by supporting communication between brain cells.

    Memantine is typically used for moderate-to-severe Alzheimer's, working through a different mechanism. Both are considered established, symptomatic treatments — not cures, but real tools with a track record.

    The Newer, More Disputed Category: Anti-Amyloid Therapies

    A newer class of drugs — lecanemab and donanemab among them — work by clearing amyloid protein buildup from the brain, and have FDA approval for early-stage Alzheimer's with confirmed amyloid pathology (requiring a PET scan or spinal fluid test to confirm). They require regular MRI monitoring for a specific safety risk (brain swelling or bleeding, known as ARIA), and they're only appropriate for a narrow group of early-stage patients.

    Here's the part worth being honest about: how meaningful their benefit actually is remains genuinely disputed. A major 2026 review examining these drugs across multiple trials found the effect on cognitive function to be minimal by clinical standards, while regulators and many dementia researchers maintain the benefit is real, if modest, for the right patients. This isn't settled science — it's an active, legitimate debate, and worth discussing directly with a neurologist rather than assuming either a dramatic breakthrough or a proven dead end.

    Non-Drug Approaches Remain a Core Part of Treatment

    Physical activity, cognitive engagement, structured routine, and social interaction aren't just "extras" alongside medication — they're considered a genuine part of managing dementia's progression and quality of life, regardless of which medications are or aren't part of the picture.

    Questions Worth Asking a Doctor

    Which category of treatment, if any, actually fits this specific diagnosis and stage? What realistic benefit should we expect, and by when? What are the monitoring requirements and risks? Is this specific patient even a candidate for the newer therapies, given their stage and other health factors?

    How Interim Fits In

    Whatever treatment plan a doctor prescribes, we're happy to support the parts around it — medication reminders, structured daily routine, and the non-medical support that makes managing any treatment plan more sustainable day to day.

    Our 7th Week Guarantee

    No long contracts. If you don't feel the difference after six weeks of care at 20 or more hours a week, your seventh week is free.

    Get Started

    Call us at (801) 401-3515 and tell us where things stand. We'll talk through what support could look like alongside whatever medical treatment is in place.

    Learn more about our dementia care services, or read about dementia stages and finding the right specialist.